U-Chart Analysis:KYORIN Pharmaceutical Co., Ltd.:4569

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index KYORIN Pharmaceutical Co., Ltd. Go to web site 4569 Medicals 東証プライム March 1, 2000 2006.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

KYORIN Pharmaceutical Co., Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2025年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2024年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2023年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2022年3月期 KYORIN Pharmaceutical Co., Ltd. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents 15,021 13,886 19,394 26,994 27,445
Other Current AssetsHelp 121,113 105,354 99,636 89,382 86,582
Tangible Fixed AssetsHelp 30,303 28,950 25,834 24,334 23,896
Intangible Fixed AssetHelp 4,757 5,088 5,393 3,289 3,785
Investments and OthersHelp 22,424 24,349 25,788 27,925 25,418
Total AssetsHelp 193,618 177,627 176,045 171,924 167,126
Total Current LiabilitiesHelp 36,630 46,333 39,741 36,240 31,020
Total Long-term LiabilitiesHelp 20,704 559 10,843 11,177 11,445
Shareholder's EquityHelp 136,284 130,735 125,461 124,507 124,661
Total LiabilitiesHelp 193,618 177,627 176,045 171,924 167,126

KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2025年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2024年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2023年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2022年3月期 KYORIN Pharmaceutical Co., Ltd. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales 130,087 119,532 113,270 105,534 102,904
Total Sales 130,087 119,532 113,270 105,534 102,904
Cost of SalesHelp 70,551 68,124 63,102 56,093 51,276
Other Costs and RevenueHelp 50,450 46,085 45,444 45,509 45,498
Total CostsHelp 121,001 114,209 108,546 101,602 96,774
Net RevenueHelp 59,536 51,408 50,168 49,441 51,628
Earnings Before TaxHelp 12,770 7,019 6,906 5,216 8,352
Net IncomeHelp 9,086 5,323 4,724 3,932 6,130
Net Income 9,086 5,323 4,724 3,932 6,130

KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2025年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2024年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2023年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2022年3月期 KYORIN Pharmaceutical Co., Ltd. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help 3,506 1,517 1,924 6,347 5,187
Investing Cash Flow(ICF)Help -6,323 -3,187 -6,275 -2,560 -4,259
Financing Cash FlowHelp 3,952 -3,347 -3,363 -4,112 -4,918
Exchange Difference of Cash and Cash EquivalentsHelp 0 87 241 139 -43
Net Increase and Decrease in Cash and Cash Equivalentsn 1,135 -4,930 -7,473 -186 -4,033

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

KYORIN Pharmaceutical Co., Ltd.
Fuji Technica & Miyazu Inc.

Company where related level is highHelp

Modalis Therapeutics Corporation
ECI,Inc.
HISAMITSU PHARMACEUTICAL CO.,INC.
Oncolys BioPharma Inc.
SymBio Pharmaceuticals Limited
Shionogi & Co.,Ltd.
Kubota Pharmaceutical Holdings Co.,Ltd.
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
Renascience Inc.
SAWAI PHARMACEUTICAL CO.,LTD.